- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Novartis’ corporate webpage listed pipeline products with indications and trial details. PMCPA ruled it promoted two licensed POMs to the public and…
Anonymous UK health professional alleged a Vifor-sponsored PIVOTAL sub-analysis symposium promoted off-licence Venofer use. Panel found PIVOTAL dosing aligned with clinically accepted…
Ex-employee alleged errors/omissions in LEO’s patient organisation support list. PMCPA found late disclosure of 2019 payments and an omitted donation; Clause 2…
UK employees ‘liked’ a US LinkedIn post linking to an Enhertu Phase 3 trial press release. Panel said the ‘likes’ proactively disseminated…
Janssen admitted it failed to oversee a nurse-led Stelara homecare service that continued after “termination”, with missing contracts, inadequate vendor PV/product training…
An invitation-only Calquence EAP “non-promotional” webinar used positive case studies and lacked certified slides. PMCPA ruled it was promotional material and that…
Anonymous employee alleged KAM “insights” sharing raised GDPR and covert marketing insight concerns, plus a training event shifting to insight gathering. Panel…
Novo Nordisk-sponsored obesity training promoted Saxenda via LinkedIn without clear upfront sponsorship, certification or prescribing info. Funding £79 Saxenda PGDs for HCPs…
Health professional alleged Roche employees’ LinkedIn ‘Experience’ sections promoted POMs without mandatory info. Panel and Appeal Board found the content was CV-style,…
Complaint alleged Shingrix promotion on an employee’s personal LinkedIn post/profile. Panel found no promotion to the public or HCPs and ruled no…
Novo Nordisk emailed HCPs about GLP-1RA supply during Lilly’s Trulicity dose outage. Panel found the wording implied Lilly didn’t prioritise supply, breaching…
Complaint alleged an email invite promoted Mayzent outside its licence, was uncertified, and didn’t clearly restrict access to HCPs. PMCPA ruled no…
PMCPA found Roche’s Rozlytrek dosing webpage misleading because it omitted key SPC dose-modification/discontinuation guidance for several safety scenarios in a black triangle…
BMJ print ad implied contraceptive pills were licensed to help skin issues, “balance hormones” and manage cycles, without qualification. Panel also found…
A supplier payment-terms letter sent to 266 UK vendors included promotional language about three medicines and an asset in development. It was…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.